| Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Outline of Final Research Achievements |
Thrombocytopenia in childhood includes inherited thrombocytopenia caused by gene mutations, in addition to non-inherited immune thrombocytopenia. Based on my basic research for Wiskott-Aldrich syndrome, I established rapid mutation analysis system for known responsible genes for inherited thrombocytopenia with small or normal-sized platelets. I also identified novel responsible gene, MECOM gene, for newly identified disease entity in three patients by exome analysis, and reported as an article worldwide. In addition, I reported the results of gene analysis to the doctors and contributed to clinical rapid diagnosis and concise management for patients with inherited thrombocytopenia with small or normal-sized platelets.
|
